These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Serological response to specific Helicobacter pylori antigens: antibody against CagA antigen is not predictive of gastric cancer in a developing country. Mitchell HM; Hazell SL; Li YY; Hu PJ Am J Gastroenterol; 1996 Sep; 91(9):1785-8. PubMed ID: 8792699 [TBL] [Abstract][Full Text] [Related]
24. Gastric cancer risk in a Mexican population: role of Helicobacter pylori CagA positive infection and polymorphisms in interleukin-1 and -10 genes. Sicinschi LA; Lopez-Carrillo L; Camargo MC; Correa P; Sierra RA; Henry RR; Chen J; Zabaleta J; Piazuelo MB; Schneider BG Int J Cancer; 2006 Feb; 118(3):649-57. PubMed ID: 16114018 [TBL] [Abstract][Full Text] [Related]
25. Serum antibodies against Helicobacter pylori proteins VacA and CagA are associated with increased risk for gastric adenocarcinoma. Rudi J; Kolb C; Maiwald M; Zuna I; von Herbay A; Galle PR; Stremmel W Dig Dis Sci; 1997 Aug; 42(8):1652-9. PubMed ID: 9286230 [TBL] [Abstract][Full Text] [Related]
26. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque. Kowalski M J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863 [TBL] [Abstract][Full Text] [Related]
27. [Studies on infection of Helicobacter pylori and their subtypes cagA+ and hspA+ in population living in the areas with high and low incidence of gastric cancer]. Zhang L; Ma J; Pan K Zhonghua Yu Fang Yi Xue Za Zhi; 1998 Mar; 32(2):67-9. PubMed ID: 10322798 [TBL] [Abstract][Full Text] [Related]
28. Evaluation of western blot CagA seropositivity in Helicobacter pylori-seropositive and -seronegative subjects. Simán JH; Engstrand L; Berglund G; Florén CH; Forsgren A Clin Diagn Lab Immunol; 2005 Feb; 12(2):304-9. PubMed ID: 15699426 [TBL] [Abstract][Full Text] [Related]
29. Association between serum pepsinogens and polymorphismof PTPN11 encoding SHP-2 among Helicobacter pylori seropositive Japanese. Goto Y; Ando T; Yamamoto K; Tamakoshi A; El-Omar E; Goto H; Hamajima N Int J Cancer; 2006 Jan; 118(1):203-8. PubMed ID: 16032704 [TBL] [Abstract][Full Text] [Related]
30. The humoral immuneresponse to Helicobacter pylori infection in children with gastrointestinal symptoms. Janulaityte-Gunther D; Kucinskiene R; Kupcinskas L; Pavilonis A; Labanauskas L; Cizauskas A; Schmidt U; Wadström T; Andersen LP FEMS Immunol Med Microbiol; 2005 May; 44(2):205-12. PubMed ID: 15866217 [TBL] [Abstract][Full Text] [Related]
31. Helicobacter pylori strain types and risk of gastric cancer: a case-control study. Enroth H; Kraaz W; Engstrand L; Nyrén O; Rohan T Cancer Epidemiol Biomarkers Prev; 2000 Sep; 9(9):981-5. PubMed ID: 11008919 [TBL] [Abstract][Full Text] [Related]
32. Epidemiology of Helicobacter pylori infection and gastric cancer in Asia. Fock KM; Ang TL J Gastroenterol Hepatol; 2010 Mar; 25(3):479-86. PubMed ID: 20370726 [TBL] [Abstract][Full Text] [Related]
33. Serum antibody positivity for distinct Helicobacter pylori antigens in benign and malignant gastroduodenal disease. Schumann C; Triantafilou K; Rasche FM; Möricke A; Vogt K; Triantafilou M; Hahn P; Schneider EM; Lepper PM Int J Med Microbiol; 2006 Aug; 296(4-5):223-8. PubMed ID: 16600680 [TBL] [Abstract][Full Text] [Related]
34. [Helicobacter pylori genotypes and their association with host's immune response]. Garza-González E; Pérez-Pérez GI; Tijerina-Menchaca R; Maldonado-Garza HJ; Bosques-Padilla FJ Rev Gastroenterol Mex; 2002; 67(3):155-60. PubMed ID: 12653051 [TBL] [Abstract][Full Text] [Related]
35. Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection. Ekström AM; Held M; Hansson LE; Engstrand L; Nyrén O Gastroenterology; 2001 Oct; 121(4):784-91. PubMed ID: 11606491 [TBL] [Abstract][Full Text] [Related]
36. [Relation between infection of CagA-positive Helicobacter pylori and upper gastrointestinal diseases]. Yang G; Hu F; Jia J Zhonghua Yi Xue Za Zhi; 2001 Jun; 81(11):648-50. PubMed ID: 11798940 [TBL] [Abstract][Full Text] [Related]
37. Helicobacter pylori and CagA seropositivity and its association with gastric and oesophageal carcinoma. Simán JH; Engstrand L; Berglund G; Forsgren A; Florén CH Scand J Gastroenterol; 2007 Aug; 42(8):933-40. PubMed ID: 17613922 [TBL] [Abstract][Full Text] [Related]
38. [Genotyping of Helicobacter pylori virulence factors vacA and cagA in individuals from two regions in Colombia with opposing risk for gastric cancer]. Trujillo E; Martínez T; Bravo MM Biomedica; 2014; 34(4):567-73. PubMed ID: 25504245 [TBL] [Abstract][Full Text] [Related]
39. The role of CagA status in gastric and extragastric complications of Helicobacter pylori. Perez-Perez GI; Peek RM; Legath AJ; Heine PR; Graff LB J Physiol Pharmacol; 1999 Dec; 50(5):833-45. PubMed ID: 10695563 [TBL] [Abstract][Full Text] [Related]
40. Carcinogenic Helicobacter pylori in gastric pre-cancer and cancer lesions: association with tobacco-chewing. Pandey A; Tripathi SC; Mahata S; Vishnoi K; Shukla S; Misra SP; Misra V; Hedau S; Mehrotra R; Dwivedi M; Bharti AC World J Gastroenterol; 2014 Jun; 20(22):6860-8. PubMed ID: 24944476 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]